Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2013
Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes
H Henary, D S Hong, G S Falchook, et al.
Investigational New Drugs
|
June 13, 2014
First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors
D S Hong, H Henary, G S Falchook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 30, 2012
Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs
A Naing, H Veasey-Rodrigues, D S Hong, et al.
ESMO Open
|
May 23, 2025
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer
D S Hong, R-H Xu, L Shen, et al.
The Korean Journal of Internal Medicine
|
June 22, 2001
A case of malignant proliferating trichilemmoma of the scalp with multiple metastases
S B Bae, K K Lee, J S Kim, et al.
Archives of Dermatological Research
|
April 22, 2016
Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors
G S Falchook, P Rady, J C Konopinski, et al.
ESMO Open
|
June 24, 2024
A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors
M A Gouda, J Shunyakova, A Naing, et al.
Investigational New Drugs
|
May 17, 2013
A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer
K H Park, J H Sohn, S Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 3, 2020
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
M Schuler, R Berardi, W-T Lim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2019
Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study
D S Hong, T M Bauer, J J Lee, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2013
Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes
H Henary, D S Hong, G S Falchook, et al.
Investigational New Drugs
|
June 13, 2014
First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors
D S Hong, H Henary, G S Falchook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 30, 2012
Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs
A Naing, H Veasey-Rodrigues, D S Hong, et al.
ESMO Open
|
May 23, 2025
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer
D S Hong, R-H Xu, L Shen, et al.
The Korean Journal of Internal Medicine
|
June 22, 2001
A case of malignant proliferating trichilemmoma of the scalp with multiple metastases
S B Bae, K K Lee, J S Kim, et al.
Archives of Dermatological Research
|
April 22, 2016
Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors
G S Falchook, P Rady, J C Konopinski, et al.
ESMO Open
|
June 24, 2024
A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors
M A Gouda, J Shunyakova, A Naing, et al.
Investigational New Drugs
|
May 17, 2013
A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer
K H Park, J H Sohn, S Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 3, 2020
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
M Schuler, R Berardi, W-T Lim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2019
Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study
D S Hong, T M Bauer, J J Lee, et al.
Page
of 5